The menstrual changes are downstream effects of metabolic changes (insulin sensitivity, weight loss), not direct hormonal interference
GLP-1 receptor agonist, liraglutide, ameliorates hepatosteatosis induced by anti-CD3 antibody in female mice
Rapid weight loss from GLP-1 medications like semaglutide can trigger telogen effluvium, a temporary hair-shedding condition affecting up to 40% of women in the first 36 months of therapy
Patients should focus on nutrient-dense foods that support muscle function, digestion, energy levels, and long-term weight maintenance
People often get fuller faster, which leads to less food consumption and, in turn, fewer necessary nutrients, Parrella added
The starting dose is 0.1 mg (50 l) three times daily and is injected subcutaneously 5 minutes before meals